Furthermore, Professor Coppari’s research team made the remarkable discovery that the S100A9-TLR4 signaling axis exerts an inhibitory effect on insulin ketogenesis in individuals with diabetes, thereby demonstrating its potential as a highly promising therapeutic target for the treatment of hyperglycemia. This evidence concerns the gene S100A9 and diabetes mellitus.